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FACTORS CONTRIBUTING TO OCCASIONAL FAILURES IN
DEMONSTRATION OF PEMPHIGUS ANTIBODIES BY
THE IMMUNOFLUORESCENCE TEST*
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ABSTRACT
The failure to demonstrate pemphigus antibodies in sera of some patients with active
lesions may be due to their species or organ specificity, to prozones, to interference
by other antibodies or to errors in technique. In vivo binding of IgG to the intercellular
areas can, however, be demonstrated in sections of biopsies of lesions even when the in-
direct staining fails to reveal the presence of pemphigus antibodies. The available evidence
indicates that all active cases of true pemphigus have pemphigus antibodies.
The detection and titration of pempbigus
antibodies has proven to be a valuable tool
in the diagnosis and control of oorticosteroid
therapy of patients with pempbigus (1, 2).
Almost all sera of active cases have demon-
strable immunofluorescent staining titers of
pemphigus antibodies (3). However, some ex-
ceptions have been encountered (4). The studies
set forth in this report show that such apparent
discrepancies may be due to species and organ
specificity of some pcmphigus antibodies, to
prozones of negative staining at low serum
dilutions or to interference phenomena caused
by the presence of other roact.ive tissue anti-
bodies in the patients' sera.
METHODS
Immuno fluorescent stoining. Fresh frozen spec-
imens of human, monkey, rabbit and guinea pig
skin and/or lip, preserved for less than one week
were sectioned in a cryostat by standard meth-
ods (5). Sera of selected cases were diluted im-
mediately before use. Immunofluorescent staining
for IgG tyoe antibodies was performed with fiuo-
rescein labeled globulin fraction of an unabsorbed
monospecific goat antiserum to human TgG. The
molar fiuorescein to protein ratio was 4:1 and the
antibody to protein ratio was 0.4. The dilution
uscd for staining contained 60 meg antibody pro-
tein per ml or about ¼ unit/mI. Further details
of the methods are given elsewhere (6). Indirect
staining for IgA type antibodies was performed
with a conjugate having a molar F/P of 4.4 and
4 units/l %/ml at a dilution containing ½ unit/mI.
For staining of 1gM type antibodies, two con-
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jugates were employed. One with molar F/P of
3.4 and 8 units/iTo P/ml was used at a dilution of
1 unit/ml and another with a molar F/P of 1.6
and 16 units/ml was employed at a dilution con-
taining 2 units/ml.
RESULTS
The serum of a patient (DYL) with clini-
cally typical oral lesions of pemphigus vulgaris
yielded consistently negative results for pem-
phigus antibodies when tested by standard in-
direct immunofluorescent methods on rabbit
and guinea pig tissue. Similarly tests for IgA
and 1gM type of pemphigus antibodies were
negative. However, histopathology revealed
acantholysis typical of pemphigus. Furthermore,
direct staining of biopsies of oral lesions for
in vivo bound IgG showed intercellular stain-
ing typical of pemphigus. Interestingly, indirect
immunofluorescent staining tests performed
with the serum of this patient on monkey lip
sections gave strongly positive reactions on oral
mucosa and hair follicle cpithelium (see Table
I). On these epithelia, the serum had a titer of
160. No reactivity could be detected on human
or monkey epidermis. Biopsies of interdental
papillae were also examined. As has been ob-
served before, such tissues do not afford satis-
factory samples of oral mucosa because the inter-
cellular antigens are lost in the areas in which
pathologic changes appear. While some reac-
tivity of pcmphigus antibodies in the sera of
DYL and MER could be detected, these oral
biopsies were unsatisfactory for titration or
other reliable studies. Serum of another pa-
tient with pcmphigus vulgaris (MER) gave a
similar species and organ specificity pattern of
reactions to that of serum DYL (see Table
I). Other tests performed on the same patient
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TABLE I
Summary of liters of pemphigtis antibodies in .sera of patients with active lesions
Tissues
Titers and intensities of indirect iminunofluorescent staining of pemphigus antibodies
DYL. MER. DEV. MAR. JOE.
Titer 1:10* Titer 1:10* Titer 1:10 Titer 1:10 Titer 1:10
Human epidermis Neg. — Neg. — 5120 +++ Neg. — 80 ++
Monkey lip epidermis
Hair follicles
Mucosa
Neg.
160
160
—
++
+++
Nag.
160
160
—
+
+
5120
2560
2560
++++
++++
++++
Nag.
40
80
—
+
++
10—20
20
SO
+
+
+
Guinea pig lip epider-
mis
Hair follicles
Mucosa
Neg.
Neg.
Neg.
—
—
—
Neg.
Nag.
Neg.
—
—
—
1O,240f
10,240
10,240
++++
++±+
++-I-+
Neg.
80
80
—
+
++
40
80
40
+
+
Rabbit lip epidermis
Hair follicles
Esophagus
Neg.
Neg.
Neg.
—
—
—
Nag.
Neg.
Neg.
—
—
2560
2560
1280
++++
+++
++++
Neg
10
80
40
40
40
+ Nag.
+ Neg.
+++ Neg.
* 1:10 Intensity of intercellular staining.
t DEV serum 10,240 highest dilution tested
Sections of epidermis from some rabbits yielded sinificantly lower titers. (See text.)
at earlier times did, however, give some limited
staining on nonprimate epithelia. This was
never the case with patient DYL.
The fact that serum from a patient with
Brazilian pemphigus foliaceus (DEV) reacts
with all antigens listed in Table I demonstrates
that all of the epithelia tested did contain
antigenic determinates capable of combining
with at least some of the pemphigus antibodies.
Many strongly reactive sera from patients with
pemphigus areas react in this way. Serum from
a patient with pemphigus vulgaris (JOR) is
an example of a weakly reactive serum which
yielded low to moderate titers on all epithelium
tested.
Another serum from a patient with Brazilian
pemphigus foliaeeus (MAR) illustrates the or-
gan specificity and a lack of species specificity
of a fairly typical weak serum. Reactivity of
this serum could be detected on monkey, guinea
pig and rabbit lip mucosa and hair follicle
epithelium, but not on the epidermis of these
species. Tissues of different rabbits yielded
variable reactions as indicated at the bottom
of Table I. For example, serum DEY gave a
titer of 320 and sera JOR and MAR were
negative when tested on sections of some rabbit
tissues.
Nuclear antibodies may interfere with the
demonstration of pcmphigus antibodies at some
serum dilutions. Table II summarizes the re-
sults of an experiment with serum (SVE) which
contained such a high titer of nuclear antibodies
that pemphigus antThodies were not demon-
strable. Table II also illustrates the effect of
partial absorption of the antinuclear factor
with guinea pig liver sediment.
As indicated in Table II, absorption of the
serum (SVE) with nuclear antigen reduced the
titer of the antinuclear antibodies from 320 to
40. Concurrently the absorption allowed de-
tection of the pemphigus antibodies. The ob-
served titer of the latter was 80, although a
prozone of negative reactions still obtained at
a lower dilution. This prozone was attributed
to interference by the residual nuclear anti-
bodies.
Essentially all fresh sera from patients with
active Brazilian pemphigus foliaceus give pro-
zones of negative staining in lower serum dilu-
tions in titrations. This is illustrated in a series
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TABLE II
Demonstration of interference phenomenon with
serum (SVE) containing muscle, nuclear and
pemphigus antibodies, from a pemphigus erythe-
niatosws patient
IF tests on monkey esophagus sections
Serum
dilutions
Indirect IF staining reactions
Unabsorbed serum Absorbed serumt
I.C.* Nuclei Stria I.C.* Nuclei Stria
10
20
40
80
160
320
-
-
-
-
—
—
+++
+++
++
+
+
+
+++
+++
++
+
—
-
-
-
+
—?
+
+
+
—
—
+++
+++
++
++
+
—
Titers Neg. 320 80 80 40 160
* I.C. = Intercellular areas (pemphigus anti-
gen).
t Absorption 1:1 of serum (1/5) and washed
sediment of guinea pig liver.
TABLE III
Preliminary titrat ions of pemphigus antibodies in
fresh frozen sera from active cases of Brazilian
pemphigus foliaceous (BPF)
Dilutions
tested
PF Sera
Pel Per
—
DgG SIL
10
40
160
640
2,560
10,220
—
—
++
+/++
+/++
—
—
:1:
++
+++
++
— —
—
—
+/++
++
+/++
—
of preliminary titrations of four sera shown in
Table III.
All four of the sera shown in Table III
yielded negative reactions at a dilution of 1: 10;
three of the four sera were even negative at a
dilution of 1: 40. However, all the sera were
strongly positive at a dilution of 1:160. Such
prozones usually disappear when sera are stored
at refrigeration temperatures. Similar prozones
have also been observed from time to time
with sera of patients suffering from non-endemic
pemphigus.
DISCUSSION
The results of these investigations on some
selected sera from patients with pemphigus
demonstrate clearly the existence of a broad
spectrum of specificities of pemphigus anti-
bodies. That is, different antisera contain anti-
bodies reactive with different antigenic deter-
minants in the intercellular substance of
different stratified squamous epithelia. Some dif-
ferences also occur between tissues of individual
rabbits. Some undocumented observations also
point to individual variations in the reactivity
of monkey epithelia and possibly that of humans.
This problem remains to be investigated.
Direct immunofluorescent staining with
labelled pemphigus antibodies and the blocking
thereof, also point to variations in the specifi-
city of pemphigus antibodies (7). This latter
study demonstrated that some, but not all, sera
could block the direct staining of the intercel-
lular area with given labelled pemphigus anti-
bodies.
Several reports (1, 2, 3) now demonstrate
that almost all cases of active pemphigus. have
in their circulation detectable levels of pem-
phigus antibodies. Some unexplained excep-
tions have, however, been encountered. It is
evident from our present studies that one
reason for such apparent exceptions is the
species specificity of some pemphigus anti-
bodies. For example, patient DYL had been
investigated for many months. All tests for
pemphigus antibodies on rabbit and guinea
pig tissues were completely negative. Yet in
vivo bound IgG could be demonstrated in the
intercellular areas in biopsies of the patients'
lesions. The clear demonstration of pemphigus
antibodies on primate tissue served to resolve
this apparent discrepancy.
Interestingly, case 3, reported by Peck
et al. (4) as a patient with active pemphigus
and no demonstrabie pemphigus antibodies,
also had specific pemphigus antibodies. In our
studies this serum had a titer of 40 on mon-
key esophagus and it gave a prozone on monkey
lip. Previous studies on guinea pig tissue had
yielded consistently negat.ive reports. An even
more extreme case encountered after the com-
pletion of these studies had a titer of 2560 on
monkey esophagus but was negative on rabbit
tissue,
It is tempting to speculate on the clinical
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relevance of the observed differences in organ
specificity of different patient sera. For exam-
ple, patient DYL had only oral lesions for many
years but developed a few skin lesions after
the sera were taken, although she was not
treated with corticosteroids prior to blood
sampling. Interestingly, her antibodies failed
to react with epidermis even of primates. On
the other hand, patient MAR had only skin
lesions but her serum reacted with hair
follicles and mucosa but not epidermis. Thus,
it is hazardous to draw conclusions from the
organ specificity of pemphigus antibodies re-
lating to the pathogenic potential of pemphigus
antibodies.
Prozones of the type set forth in this report
constitute an additional phenomenon which
may cause false negative im.munofluorescent
staining reactions. The mechanisms of such
prozones remain to be elucidated. Interestingly,
such prozones can be produced by mixing
fresh normal human sera with positive sera
containing high titers of pemphigus antibodies.
Various mechanisms might be considered here:
(a) The prozones might be due to t.he presence
of intercellular antigens in sera. (These, of
course, would lead to the formation of antigen-
antibody complexes in the serum.) (b) They
might be due to blocking antibodies. (c) They
could possibly be due to rheumatoid factor
which is present in most pemphigus sera. (d)
They could be due to enzymatic degradation of
1able intercellular antigens either by enzymes
in fresh sera or by the serum activation of
enzymes present in the cryostat. cut sections
which serve as substrate.
Interference phenomena, due to the presence
of multiple tissue antibodies, have been oh-
served in several fluorescent antibody staining
systems (8, 9, 10). This interference phenomen
appears to be due to the consumption of the
labelled antiglobulin by one of the reactive tissue
antibodies to the exclusion of the others. Ef-
forts to reveal the other antibodies by repeated
incubation of sections with fresh conjugate pro-
duced only strong nonspecific staining which
masks specific immunofluorescent patterns.
Errors in technique may also lead to false
negative results. These may include inadequately
reactive conjugate, improper handling of anti-
gen or sera. These problems are discussed in
other reports (0, 11). It should be stressed
that in vivo binding of IgG to the intercellular
substance can be demonstrated even when prob-
lems arise in the detection of the circulating
antibodies, which appear to be present in all
active cases of pemphigus.
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